FB 04 - Universitätsmedizin
Johannes Gutenberg-Universität Mainz
- 06131/17-9704 oder 9799 (Sekretariat)
- 06131/17-9669
Xia, N.; Hasselwander, S.; Ascher, S. et al.
B lymphocyte-Deficiency in mice promotes venous thrombosis -Role of NeutrophilsNAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY. Bd. 395. H. SUPPL 1. 2022 S. S8-S8
Roewe, Julian; Walachowski, Sarah; Sharma, Arjun et al.
Bacterial polyphosphates induce CXCL4 and synergize with complement anaphylatoxin C5a in lung injuryFRONTIERS IN IMMUNOLOGY. Bd. 13. 2022
Krenzlin, Viola; Roewe, Julian; Strueve, Marcel et al.
Bacterial-Type Long-Chain Polyphosphates Bind Human Proteins in the Phosphatidylinositol Signaling PathwayTHROMBOSIS AND HAEMOSTASIS. Bd. 122. H. 11. 2022 S. 1943-1947
Fischer, KD
Bagni di sabbia fervida: Paul. Nic. 61 e Cass. Fel. 76.14Galenos. Bd. 15. 2022 S. 27-31
Depenbusch, J.; Sweegers, M.; Aaronson, N. et al.
Barriers, facilitators, and preferences to exercise interventions in patients with metastatic breast cancer: A qualitative study in four European countriesANNALS OF ONCOLOGY. Bd. 33. H. 7. 2022 S. S1261-S1261
Hausen, Anne; Huppertz, Tilman; Gaida, Matthias M.
Basal cell adenoma of the parotid glandPATHOLOGIE. 2022
Yassen, Ashraf; Coboeken, Katrin; Bailly, Sebastien et al.
Baseline clusters and the response to positive airway pressure treatment in obstructive sleep apnoea patients: longitudinal data from the European Sleep Apnea Database cohortERJ OPEN RESEARCH. Bd. 8. H. 4. 2022
Mueller, Lukas; Gairing, Simon Johannes; Kloeckner, Roman et al.
Baseline Splenic Volume Outweighs Immuno-Modulated Size Changes with Regard to Survival Outcome in Patients with Hepatocellular Carcinoma under ImmunotherapyCANCERS. Bd. 14. H. 15. 2022
Hoffmeister-Wittmann, Paula; Mock, Andreas; Nichetti, Federico et al.
Bcl-x(L) as prognostic marker and potential therapeutic target in cholangiocarcinomaLIVER INTERNATIONAL. Bd. 42. H. 12. 2022 S. 2855-2870
Cavalieri, S.; Vener, C.; LeBlanc, M. et al.
BD4QoL: A multicenter randomized trial for monitoring quality of life (QoL) by intelligent tools in head and neck cancer (HNC) survivors after curative treatmentANNALS OF ONCOLOGY. Bd. 33. H. 7. 2022 S. S866-S866